Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma
- 30 June 1996
- journal article
- clinical trial
- Published by Elsevier in Immunopharmacology
- Vol. 33 (1-3) , 238-242
- https://doi.org/10.1016/0162-3109(96)00065-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigsBritish Journal of Pharmacology, 1994
- Bradykinin-induced airway inflammation. Contribution of sensory neuropeptides differs according to airway site.American Journal of Respiratory and Critical Care Medicine, 1994
- Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea.The Journal of Immunology, 1993
- Effect of Hoe 140 on Bradykinin-induced Bronchoconstriction in Anesthetized Guinea PigsAmerican Review of Respiratory Disease, 1993
- Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pigEuropean Journal of Pharmacology, 1992
- Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studiesBritish Journal of Pharmacology, 1991
- Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studiesBritish Journal of Pharmacology, 1991
- Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects.Journal of Clinical Investigation, 1987
- Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogsJournal of Applied Physiology, 1980